10.17.12
TSI Group, Missoula, MT, in collaboration with its research and product development partner Metabolic Technologies, Inc., Ames, IA, has released details on a Peak ATP clinical study, which was published in the Journal of the International Society of Sports Nutrition (JISSN). The randomized, placebo-controlled, double-blind, crossover study assessed the performance-enhancing effects of 200 mg of Peak ATP consumed twice per day for 15 days in healthy active adults, versus placebo, on measures of maximum strength, total work and muscle fatigue. The results revealed 400 mg of Peak ATP per day reduced muscular fatigue in subjects performing repeated maximal effort sets of knee extension and flexion, and 400 mg of Peak ATP per day allowed subjects to maintain greater muscle strength as measured by torque while performing repeated sets of maximal effort knee extension and flexion. Researchers concluded that these effects might indicate an improvement in overall training stimulus, which may have been brought about by more rapid repolarization and stronger action potentials later within sets.
For further information: www.jissn.com
For further information: www.jissn.com
